Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 8:10:1219611.
doi: 10.3389/fcvm.2023.1219611. eCollection 2023.

Feasibility and safety of the direct current cardioversion at the time of left atrial appendage occlusion for patients with atrial fibrillation

Xian Sai Meng #  1 , Tao Chen #  1 , Xin Yan Wang  1 , Xu Lu  1 , Jia Hu  1 , Juan Shen  1 , Jun Guo  1
Affiliations

Feasibility and safety of the direct current cardioversion at the time of left atrial appendage occlusion for patients with atrial fibrillation

Xian Sai Meng et al. Front Cardiovasc Med. .

Abstract

Background: With an increasing number of patients undergoing left atrial appendage occlusion (LAAO), more attention is being paid to relieving clinical symptoms and improving the quality of life of these patients. For patients with atrial fibrillation (AF), direct current cardioversion (DCCV) is an alternate, nonpharmacological choice to restore sinus rhythm and relieve clinical symptoms.

Objectives: The purpose of this study was to assess the feasibility and safety of the DCCV at the time of LAAO for patients with AF.

Methods: Forty patients were enrolled in the DCCV group undergoing the DCCV at the time of LAAO. The control group undergoing LAAO alone was formed by 1:1 matching.

Results: In the DCCV group, cardioversion was immediately successful in 30 (75%) patients, of which 12 (40%) had AF recurrence at the three-month follow-up. The failed-DCCV group was older (73.70 ± 4.74 vs. 62.20 ± 9.01 years old, P = 0.000), had a faster postcardioversion heart rate (88.80 ± 16.58 vs. 70.97 ± 14.73 times, P = 0.03), and had a higher mean HAS-BLED score (4.00 vs. 3.00, P = 0.01) than the successful-DCCV group. No patients experienced periprocedural pericardial effusion, occluder displacement, device embolism, or >5 mm peridevice leakage. One patient experienced a transient ischemic attack (TIA) in the DCCV group during the follow-up.

Conclusions: The DCCV at the time of LAAO is feasible and safe for AF patients with contraindications for catheter ablation or AF recurrence after previous catheter ablation to restore the sinus rhythm and relieve clinical symptoms. The DCCV at the time of LAAO is more likely to succeed for younger patients and patients with lower HAS-BLED scores.

Keywords: atrial fibrillation; direct current cardioversion; left atrial appendage; left atrial appendage occlusion; stroke.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The changes in patients' symptoms..
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. (1996) 61(2):755–9. 10.1016/0003-4975(95)00887-X - DOI - PubMed
    1. Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy. J Am Coll Cardiol. (2014) 64(1):1–12. 10.1016/j.jacc.2014.04.029 - DOI - PubMed
    1. Karlsson LO, Nilsson S, Bang M, Nilsson L, Charitakis E, Janzon M. A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: a cluster-randomized trial in a Swedish primary care setting (the CDS-AF study). PLos Med. (2018) 15(3):17. 10.1371/journal.pmed.1002528 - DOI - PMC - PubMed
    1. Zimetbaum P. Atrial fibrillation. Ann Intern Med. (2017) 166(5):ITC33–47. 10.7326/AITC201703070 - DOI - PubMed
    1. Collado FMS, von Buchwald CLM, Anderson CK, Madan N, Suradi HS, Huang HD, et al. Left atrial appendage occlusion for stroke prevention in nonvalvular atrial fibrillation. J Am Heart Assoc. (2021) 10(21):18. 10.1161/JAHA.121.022274 - DOI - PMC - PubMed

LinkOut - more resources